Apolipoprotein E e4 allele affects risk of hyperhomocysteinemia in the elderly - PubMed (original) (raw)
. 2006 Dec;84(6):1473-80.
doi: 10.1093/ajcn/84.6.1473.
Affiliations
- PMID: 17158432
- DOI: 10.1093/ajcn/84.6.1473
Free article
Apolipoprotein E e4 allele affects risk of hyperhomocysteinemia in the elderly
Giovanni Ravaglia et al. Am J Clin Nutr. 2006 Dec.
Free article
Abstract
Background: Apolipoprotein E (APOE) plays a central role in VLDL metabolism. Both APOE e4 allele (APOE4) and C-reactive protein (CRP) are associated with greater risk of dementia and vascular disease, but APOE4 carriers have lower blood concentrations of CRP than do noncarriers, possibly through a mechanism favoring the clearance of the CRP VLDL-bound fraction. Homocysteine, another risk factor for vascular disease and dementia, also binds to VLDL in blood. However, the association between APOE4 and hyperhomocysteinemia has never been thoroughly investigated.
Objective: We investigated in an elderly population whether 1) APOE4 is associated with hyperhomocysteinemia [plasma total homocysteine (tHcy) > 15 micromol/L], 2) hyperhomocysteinemia affects the association between APOE4 and high CRP (serum CRP > 3 mg/L), and 3) B vitamin status affects these associations.
Design: APOE4 genotypes were assessed and tHcy, CRP, and serum concentrations of folate and vitamin B-12 were measured in 671 cognitively healthy subjects (52% women; mean age: 73 y) from an Italian population-based prospective cohort study.
Results: APOE4 carriers without high CRP [multivariate-adjusted odds ratio (OR): 0.22; 95% CI: 0.08, 0.59] had a lower risk of hyperhomocysteinemia than did noncarriers. The risk of high CRP was lower in APOE4 carriers without hyperhomocysteinemia (multivariate-adjusted OR: 0.51; 95% CI: 0.31, 0.85) than in noncarriers. The associations were not affected by B vitamin status.
Conclusion: Independently from B vitamin status, APOE4 carriers have a lower risk of hyperhomocysteinemia and of high CRP than do noncarriers, but the presence of one condition attenuates the association of APOE4 with the other condition.
Similar articles
- Homocysteine and cognitive function in healthy elderly community dwellers in Italy.
Ravaglia G, Forti P, Maioli F, Muscari A, Sacchetti L, Arnone G, Nativio V, Talerico T, Mariani E. Ravaglia G, et al. Am J Clin Nutr. 2003 Mar;77(3):668-73. doi: 10.1093/ajcn/77.3.668. Am J Clin Nutr. 2003. PMID: 12600859 - Homocysteine and folate as risk factors for dementia and Alzheimer disease.
Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F. Ravaglia G, et al. Am J Clin Nutr. 2005 Sep;82(3):636-43. doi: 10.1093/ajcn.82.3.636. Am J Clin Nutr. 2005. PMID: 16155278 - Plasma homocysteine, apolipoprotein E status and vascular disease in elderly patients with mental illness.
Nilsson K, Gustafson L, Nornholm M, Hultberg B. Nilsson K, et al. Clin Chem Lab Med. 2010;48(1):129-35. doi: 10.1515/CCLM.2010.013. Clin Chem Lab Med. 2010. PMID: 19943806 - The worldwide challenge of the dementias: a role for B vitamins and homocysteine?
Smith AD. Smith AD. Food Nutr Bull. 2008 Jun;29(2 Suppl):S143-72. doi: 10.1177/15648265080292S119. Food Nutr Bull. 2008. PMID: 18709889 Review. - Hyperhomocysteinemia and immune activation.
Schroecksnadel K, Frick B, Winkler C, Leblhuber F, Wirleitner B, Fuchs D. Schroecksnadel K, et al. Clin Chem Lab Med. 2003 Nov;41(11):1438-43. doi: 10.1515/CCLM.2003.221. Clin Chem Lab Med. 2003. PMID: 14656023 Review.
Cited by
- ApoE isoforms, treatment of diabetes and the risk of coronary heart disease.
Ehara H, Yamamoto-Honda R, Kitazato H, Takahashi Y, Kawazu S, Akanuma Y, Noda M. Ehara H, et al. World J Diabetes. 2012 Mar 15;3(3):54-9. doi: 10.4239/wjd.v3.i3.54. World J Diabetes. 2012. PMID: 22442750 Free PMC article. - Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly.
Haan MN, Mayeda ER. Haan MN, et al. Curr Cardiovasc Risk Rep. 2010 Sep;4(5):361-368. doi: 10.1007/s12170-010-0118-4. Epub 2010 Jul 16. Curr Cardiovasc Risk Rep. 2010. PMID: 20694037 Free PMC article. - Homocysteine, Cognitive Functions, and Degenerative Dementias: State of the Art.
Luzzi S, Cherubini V, Falsetti L, Viticchi G, Silvestrini M, Toraldo A. Luzzi S, et al. Biomedicines. 2022 Oct 28;10(11):2741. doi: 10.3390/biomedicines10112741. Biomedicines. 2022. PMID: 36359260 Free PMC article. Review. - Influence of Dietary Supplementation for Hyperhomocysteinemia Treatments.
Vezzoli A, Dellanoce C, Caimi TM, Vietti D, Montorsi M, Mrakic-Sposta S, Accinni R. Vezzoli A, et al. Nutrients. 2020 Jun 30;12(7):1957. doi: 10.3390/nu12071957. Nutrients. 2020. PMID: 32630031 Free PMC article. Clinical Trial. - Hyperhomocysteinemia-Induced Monocyte Chemoattractant Protein-1 Promoter DNA Methylation by Nuclear Factor-κB/DNA Methyltransferase 1 in Apolipoprotein E-Deficient Mice.
Wang J, Jiang Y, Yang A, Sun W, Ma C, Ma S, Gong H, Shi Y, Wei J. Wang J, et al. Biores Open Access. 2013 Apr;2(2):118-27. doi: 10.1089/biores.2012.0300. Biores Open Access. 2013. PMID: 23593564 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous